DocGo Inc. (NASDAQ:DCGO) Shares Bought by AQR Capital Management LLC

AQR Capital Management LLC grew its holdings in shares of DocGo Inc. (NASDAQ:DCGO) by 58.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 344,963 shares of the company’s stock after buying an additional 127,320 shares during the quarter. AQR Capital Management LLC owned 0.34% of DocGo worth $1,066,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in DCGO. Squarepoint Ops LLC grew its holdings in DocGo by 43.8% during the 2nd quarter. Squarepoint Ops LLC now owns 224,197 shares of the company’s stock worth $693,000 after acquiring an additional 68,264 shares in the last quarter. Marshall Wace LLP lifted its position in shares of DocGo by 212.4% during the second quarter. Marshall Wace LLP now owns 505,514 shares of the company’s stock worth $1,562,000 after purchasing an additional 343,692 shares during the last quarter. XTX Topco Ltd acquired a new position in DocGo in the second quarter worth about $211,000. Isthmus Partners LLC increased its holdings in DocGo by 32.4% in the second quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock valued at $25,000 after buying an additional 195,428 shares during the last quarter. Finally, Victory Capital Management Inc. raised its stake in DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after buying an additional 14,191 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Price Performance

DCGO stock opened at $3.26 on Friday. The stock has a market capitalization of $331.11 million, a price-to-earnings ratio of 16.30, a price-to-earnings-growth ratio of 2.73 and a beta of 0.91. The company has a 50-day moving average of $3.45 and a two-hundred day moving average of $3.35. DocGo Inc. has a 52-week low of $2.75 and a 52-week high of $6.90.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). DocGo had a return on equity of 8.90% and a net margin of 3.97%. The business had revenue of $164.95 million for the quarter, compared to analyst estimates of $166.61 million. Equities analysts expect that DocGo Inc. will post 0.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and set a $7.00 price objective on shares of DocGo in a research note on Thursday, August 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $5.00 target price on shares of DocGo in a research note on Friday, September 20th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, DocGo currently has a consensus rating of “Buy” and a consensus price target of $6.10.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.